[go: up one dir, main page]

PT101165A - Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase - Google Patents

Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase

Info

Publication number
PT101165A
PT101165A PT101165A PT10116592A PT101165A PT 101165 A PT101165 A PT 101165A PT 101165 A PT101165 A PT 101165A PT 10116592 A PT10116592 A PT 10116592A PT 101165 A PT101165 A PT 101165A
Authority
PT
Portugal
Prior art keywords
oxygenase
synthesis
cycle
preparation
inhibitors
Prior art date
Application number
PT101165A
Other languages
English (en)
Other versions
PT101165B (pt
Inventor
Pierre Braquet
Colette Broquet
Pierre-Etienne Cha Lassauniere
Serge Auvin
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of PT101165A publication Critical patent/PT101165A/pt
Publication of PT101165B publication Critical patent/PT101165B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/04—Mono-, di- or tri-methylamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT101165A 1992-01-04 1992-12-30 Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase PT101165B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200114A GB9200114D0 (en) 1992-01-04 1992-01-04 Dual inhibitors of no synthase and cyclooxygenase

Publications (2)

Publication Number Publication Date
PT101165A true PT101165A (pt) 1994-02-28
PT101165B PT101165B (pt) 1999-09-30

Family

ID=10708115

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101165A PT101165B (pt) 1992-01-04 1992-12-30 Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase

Country Status (34)

Country Link
US (2) US5480999A (pt)
JP (1) JP2984498B2 (pt)
KR (1) KR100287539B1 (pt)
AT (1) AT401054B (pt)
AU (1) AU664399B2 (pt)
BE (1) BE1006227A3 (pt)
CA (1) CA2085555C (pt)
CH (1) CH685629A5 (pt)
DE (1) DE4244539B4 (pt)
DK (1) DK157592A (pt)
DZ (1) DZ1657A1 (pt)
ES (1) ES2052452B1 (pt)
FI (1) FI925883A (pt)
FR (2) FR2685916B1 (pt)
GB (2) GB9200114D0 (pt)
GR (1) GR1001443B (pt)
HK (1) HK22296A (pt)
HU (1) HU220218B (pt)
IE (1) IE71675B1 (pt)
IT (1) IT1256761B (pt)
LU (1) LU88208A1 (pt)
MA (1) MA22753A1 (pt)
MY (1) MY109846A (pt)
NL (1) NL194889C (pt)
NO (1) NO302943B1 (pt)
NZ (1) NZ245499A (pt)
OA (1) OA10050A (pt)
PL (1) PL169432B1 (pt)
PT (1) PT101165B (pt)
RU (1) RU2104999C1 (pt)
SE (1) SE511568C2 (pt)
TN (1) TNSN93001A1 (pt)
TW (1) TW267152B (pt)
ZA (1) ZA9210080B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500138A (ja) * 1994-05-07 1998-01-06 アストラ・アクチエボラーグ 酸化窒素合成酵素阻害剤としての２環アミジン誘導体
DE69534118T2 (de) * 1994-05-11 2006-02-09 Jes Olesen Verwendung der no-faenger, inhibitoren oder antagonisten zur behandlung von migraene
CA2132690A1 (en) * 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
DE793646T1 (de) 1994-11-23 1999-12-30 Pharmacia & Upjohn Co., Kalamazoo Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus
JPH08333258A (ja) 1994-12-14 1996-12-17 Japan Tobacco Inc チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
ES2096524B1 (es) * 1994-12-22 1997-11-16 Sanchez Manuel Guerra Uso de la ng-monometil-l-arginina, para aumentar la capacidad de hacer ejercicio fisico.
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
GB9514518D0 (en) * 1995-07-15 1995-09-13 Sod Conseils Rech Applic Guanidine salt inhibitors of NO synthase and cyclooxygenase
AU2063397A (en) * 1996-03-05 1997-09-22 Children's Hospital Medical Center Mercapto derivatives as inhibitors of cyclooxygenases
WO1997044324A1 (en) 1996-05-21 1997-11-27 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US7345051B2 (en) * 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
JP2004507444A (ja) * 2000-01-31 2004-03-11 ジェネーラ　コーポレーション ムチン合成インヒビター
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7244753B2 (en) * 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
ATE546134T1 (de) * 2002-12-26 2012-03-15 Pozen Inc Mehrschichtige dosierformen enthaltend naproxen und triptane
BRPI0410807A (pt) * 2003-06-06 2006-06-27 Glaxo Group Ltd composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica
WO2004113286A2 (en) * 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors
EP1638612A4 (en) * 2003-06-25 2010-09-29 Univ Vanderbilt COX-2-MADE DISPLAY AGENTS
US7491744B2 (en) * 2004-04-26 2009-02-17 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
EP1836296A1 (en) * 2005-01-04 2007-09-26 Novartis AG X-ray structure of human fpps and use for selecting fpps binding compounds
CA2657691A1 (en) * 2006-06-19 2007-12-27 Vanderbilt University Methods and compositions for diagnostic and therapeutic targeting of cox-2
EP3078374B1 (en) 2011-10-17 2019-06-19 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
TWM469254U (zh) 2013-08-29 2014-01-01 J D Components Co Ltd 自行車之三件式豎管

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6838M (pt) * 1967-12-08 1969-03-31
ES423794A1 (es) * 1974-03-01 1976-05-01 Medicinales S A Promesa Prod Procediemiento de obtencion de una nueva sal soluble de acido acetilsalicilico.
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127274B (it) * 1979-12-04 1986-05-21 Selvi & C Spa Sali dell'acido 5-fluoro-2-metil-1-(p-(metilsulfinil)-benzilidene)-indene-3-acetico
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
CA1213888A (en) * 1983-09-28 1986-11-12 Warner-Lambert Company L-arginine isoxicamate
US5081184A (en) * 1985-08-02 1992-01-14 General Electric Company Solvent-resistant, compatible blends of polyphenylene ethers and linear polyesters
JPS6393718A (ja) * 1986-10-07 1988-04-25 Green Cross Corp:The 注射剤
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
EP0424028B1 (en) * 1989-10-17 1995-09-27 Merck & Co. Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth

Also Published As

Publication number Publication date
ES2052452B1 (es) 1995-02-01
SE9203825D0 (sv) 1992-12-18
RU2104999C1 (ru) 1998-02-20
SE511568C2 (sv) 1999-10-18
NO302943B1 (no) 1998-05-11
IE71675B1 (en) 1997-02-26
NL194889B (nl) 2003-02-03
US5360925A (en) 1994-11-01
DK157592D0 (da) 1992-12-30
DE4244539A1 (pt) 1993-07-08
DE4244539B4 (de) 2006-10-26
LU88208A1 (fr) 1993-04-15
FR2685869A1 (fr) 1993-07-09
DK157592A (da) 1993-07-05
GB2263111B (en) 1995-08-16
CA2085555A1 (en) 1993-07-05
ATA256092A (de) 1995-10-15
AU3049892A (en) 1993-07-08
PT101165B (pt) 1999-09-30
CA2085555C (en) 2004-07-20
MY109846A (en) 1997-08-30
IE922954A1 (en) 1993-07-14
GB2263111A (en) 1993-07-14
GR1001443B (el) 1993-12-30
ITMI922953A1 (it) 1994-06-23
NL194889C (nl) 2003-06-04
HK22296A (en) 1996-02-16
GB9227026D0 (en) 1993-02-17
OA10050A (fr) 1996-10-14
FR2685869B1 (fr) 1995-06-09
NO924835L (no) 1993-07-05
MA22753A1 (fr) 1993-07-01
KR930016389A (ko) 1993-08-26
TW267152B (pt) 1996-01-01
ZA9210080B (en) 1993-08-02
FI925883A0 (fi) 1992-12-28
NL9300001A (nl) 1993-08-02
CH685629A5 (fr) 1995-08-31
HU220218B (hu) 2001-11-28
PL297247A1 (en) 1993-09-06
TNSN93001A1 (fr) 1994-03-17
BE1006227A3 (fr) 1994-06-14
IT1256761B (it) 1995-12-15
SE9203825L (sv) 1993-07-05
ES2052452A1 (es) 1994-07-01
DZ1657A1 (fr) 2002-02-17
JP2984498B2 (ja) 1999-11-29
JPH05286916A (ja) 1993-11-02
AT401054B (de) 1996-06-25
FR2685916A1 (fr) 1993-07-09
FI925883A (fi) 1993-07-05
HUT64047A (en) 1993-11-29
GB9200114D0 (en) 1992-02-26
PL169432B1 (pl) 1996-07-31
NO924835D0 (no) 1992-12-14
US5480999A (en) 1996-01-02
AU664399B2 (en) 1995-11-16
FR2685916B1 (fr) 2001-09-28
KR100287539B1 (ko) 2001-04-16
HU9204173D0 (en) 1993-04-28
NZ245499A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
PT101165A (pt) Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9508927A (pt) Processo para a preparação de compostos e composto
BR8902310A (pt) Processo para a preparacao de dialquil dissulfetos e polissulfetos
BR9301180A (pt) Processo para a preparacao de isocianatos e emprego
BR9500613A (pt) Processo para a preparação contínua de mononitrotoluenos
BR9600254A (pt) Composto processo para a sua preparação seus usos método para o tratamento de arritmias e medicamento contendo o mesmo
BR9505251A (pt) Processo para a fabricação de um composto e composto obtido
BR8903429A (pt) Heteropolissacarideo bm07 e processo para a preparacao do mesmo e aplicacao do heteropolissacarideo bm07
BR9301399A (pt) Processo para a preparacao de um monoazocorante
BR9205129A (pt) Processo para a preparacao de isocianatos puros
BR9203974A (pt) Processo para a preparacao de compostos e aplicacao de triacoolatos e fenolatos
BR9301676A (pt) Processo para a preparacao de 1,1,1,4,4,4-hexafluorbutano e compostos obtidos
ITMI921157A0 (it) Processo per la preparazione di alchilpoliglucosidi
PT89954B (pt) Processo para a preparacao de pirroloquinolina-e pirrolofenotiazina-carboxamidas e de compostos afins
BR9505571A (pt) Oligômero composto medicamento processo para a produção de um medicamento e uso
PT91235A (pt) Processo para a preparacao de novos inibidores da s-adenosil-metionina-descarboxilase
BR9307043A (pt) Processo para preparação de dinitro-tolueno
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos
BR9602731A (pt) Processo para a preparação de hidroxibiarilfosfinas e hidroxibiarilfosfina assim obtidas
PT89810A (pt) Processo para a preparacao de imidazolinonas e imidazolinotionas substituidas
BR9611833A (pt) Processo para a preparação de dioxoazabiciclo-hexanos
BR9306348A (pt) Processo para a preparação de hexafluorbutano
BR9505216A (pt) Processo para a preparação de 3-hidróxi-n-benzimidazolon-5-il- 2-naftamida

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930721

FG3A Patent granted, date of granting

Effective date: 19990624

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20091228